论文部分内容阅读
目的 :评价经尿道等离子前列腺剜除术与经尿道等离子电切术比较治疗前列腺增生(BPH)的疗效和安全性。方法 :回顾分析2012年1月~2014年12月86例符合纳入标准的BPH患者,44例经尿道前列腺等离子体电切术,42例经尿道前列腺剜除术为研究对象,对患者术前、术后随访6个月时的前列腺症状评分(IPSS)、生活质量评分(QOL)、最大尿流率(Qmax)、残余尿量(PVR)等以及术中失血、手术时间、尿管留置时间和术后不良反应等临床指标进行统计分析。结果 :术中临床指标显示,剜除组在术中冲洗液的血红蛋白丢失量、手术时间、尿管留置时间方面均优于电切组;但术后短暂性尿失禁发生高于电切组,且差异均有统计学意义。术后随访6个月的结果显示,两组在IPSS、QOL、Qmax、PVR等方面差异无统计学意义,且两组患者术后均未出现长期尿失禁、尿道狭窄和继发性出血。结论 :经尿道等离子前列腺剜除术具有术中出血少及手术时间短的优点,是治疗良性前列腺增生症的一种有效的手术方法。
Objective: To evaluate the efficacy and safety of transurethral plasma prostatectomy and transurethral resection of plasma in the treatment of benign prostatic hyperplasia (BPH). Methods: A retrospective analysis of 86 cases of BPH patients who met the inclusion criteria from January 2012 to December 2014, 44 cases of transurethral resection of prostate gland and 42 cases of transurethral resection of the prostate were included in this study. Prostate symptom score (IPSS), quality of life score (QOL), maximal flow rate (Qmax) and residual urine volume (PVR) at 6 months postoperative follow-up and blood loss during operation, operation time and catheter indwelling time Postoperative adverse reactions and other clinical indicators for statistical analysis. Results: Intraoperative clinical indexes showed that the blood loss of hemoglobin, operation time and catheter indwelling time of the flushing group were better than that of the resection group in surgery group, but the incidence of transient urinary incontinence was higher than that of the resection group, And the differences were statistically significant. Postoperative follow-up of 6 months showed no significant difference in IPSS, QOL, Qmax and PVR between the two groups. Long-term urinary incontinence, urethral stricture and secondary hemorrhage were not observed in both groups. Conclusion: Transurethral plasma prostatectomy has the advantages of less intraoperative bleeding and shorter operative time, and is an effective surgical method for the treatment of benign prostatic hyperplasia.